5 Defensive Stocks to Watch as CPI and the Fed Put the Rally to the Test Ahead of CPI data and the Fed's rate decision, defensive stocks McDonald's, Johnson & Johnson, Walmart, Berkshire Hathaway, and NextEra Energy offer stability and dividends amid market uncertainty.
If the Fed Hikes Interest Rates This Month, History Says This Is the Smartest ETF to Buy Right Now If interest rates rise, writing a prescription today for the State Street Health Care Select Sector SPDR ETF is a smart idea.
Intuitive Surgical's Growth Has Cooled From Its Post-Pandemic Highs. Is That a Buying Opportunity or a Warning? Intuitive Surgical's flywheel isn't selling new surgical robots, its selling parts and services to support the ones it has already sold.
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.
Warren Buffett Thinks Investors Are "Gambling" Right Now. Here are 2 Stocks That Should Be Safe Bets. Johnson & Johnson and Merck are healthcare giants with dependable returns that weather economic downturns well.
I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now Looking for a dividend stock you can sleep well owning? Here's why Johnson & Johnson could be the long-term healthcare anchor your portfolio needs.
Johnson & Johnson Just Got a Big FDA Win The company's autoimmune drug was approved for the treatment of a rare blood disease.
Johnson & Johnson Secures FDA Approval For First Rare Anemia Treatment Johnson & Johnson secured FDA approval for IMAAVY, the first targeted therapy to treat warm autoimmune hemolytic anemia in adults and youth.
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? These two high-quality dividend payers have had very different fortunes recently.
